Fig. 5.

Effects of systemic treatment with FG7142 (0.0–5.5 mg/kg, i.p.) on performance variables in operant SNC. A significant main effect of DOSE was observed for correct latency and premature responding. No main effect of SESSION was seen for any of the four recorded variables. Results are shown as mean ± SEM, n = 12 animals per group, within-subject, *p < 0.05, **p < 0.01, ***p < 0.001 pairwise comparison between baseline and devalue session following vehicle pretreatment #p < 0.05, ##p < 0.01 pairwise comparison vehicle vs drug on baseline or devalue sessions